CONCENTRIX ($CNXC) is expected to release its quarterly earnings data on Thursday, September 25th after market close, per Finnhub. Analysts are expecting revenue of $2,506,695,492 and earnings of $2.92 per share.
You can see Quiver Quantitative's $CNXC stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
CONCENTRIX Insider Trading Activity
CONCENTRIX insiders have traded $CNXC stock on the open market 16 times in the past 6 months. Of those trades, 1 have been purchases and 15 have been sales.
Here’s a breakdown of recent trading of $CNXC stock by insiders over the last 6 months:
- OLIVIER DUHA has made 0 purchases and 10 sales selling 108,843 shares for an estimated $5,274,970.
- CORMAC J TWOMEY (EVP, Global Ops & Delivery) has made 0 purchases and 5 sales selling 2,500 shares for an estimated $135,615.
- CHRISTOPHER A CALDWELL (President and CEO) purchased 1,000 shares for an estimated $46,000
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CONCENTRIX Hedge Fund Activity
We have seen 169 institutional investors add shares of CONCENTRIX stock to their portfolio, and 203 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AQR CAPITAL MANAGEMENT LLC added 875,556 shares (+25.5%) to their portfolio in Q2 2025, for an estimated $46,277,512
- DIMENSIONAL FUND ADVISORS LP added 552,890 shares (+51.0%) to their portfolio in Q2 2025, for an estimated $29,223,000
- DEPRINCE RACE & ZOLLO INC removed 501,339 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $26,498,272
- CAUSEWAY CAPITAL MANAGEMENT LLC removed 409,812 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $22,801,939
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 381,497 shares (+247.2%) to their portfolio in Q2 2025, for an estimated $20,164,023
- CAPITAL MANAGEMENT CORP /VA added 325,993 shares (+inf%) to their portfolio in Q2 2025, for an estimated $17,230,360
- ALYESKA INVESTMENT GROUP, L.P. removed 292,091 shares (-56.7%) from their portfolio in Q2 2025, for an estimated $15,438,469
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CONCENTRIX Analyst Ratings
Wall Street analysts have issued reports on $CNXC in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Baird issued a "Outperform" rating on 09/18/2025
- Canaccord Genuity issued a "Buy" rating on 06/30/2025
- Barrington Research issued a "Outperform" rating on 06/27/2025
To track analyst ratings and price targets for CONCENTRIX, check out Quiver Quantitative's $CNXC forecast page.
CONCENTRIX Price Targets
Multiple analysts have issued price targets for $CNXC recently. We have seen 4 analysts offer price targets for $CNXC in the last 6 months, with a median target of $68.5.
Here are some recent targets:
- Joseph Vafi from Canaccord Genuity set a target price of $80.0 on 09/23/2025
- David Koning from Baird set a target price of $75.0 on 09/18/2025
- Ruplu Bhattacharya from B of A Securities set a target price of $61.0 on 06/27/2025
- Vincent Colicchio from Barrington Research set a target price of $62.0 on 06/27/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
